Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti–PD-L1 Immunotherapy Be Administered after Anti–PD-1–Related Immune Toxicities?Umang Swami,Petar Lenert,Muhammad Furqan,Taher Abu Hejleh,Gerald Clamon,Jun ZhangJournal of Thoracic Oncology（2018）引用 9|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
